The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma

Rachel Elizabeth Ann Fincham; Parthiban Periasamy; Craig Ryan Joseph; Jia Meng; Jeffrey Chun Tatt Lim; Felicia Wee; Konstantinos Stasinos; Michelle Rodrigues Goulart; Jiangfeng Ye; Li Yen Chong; Bijin Veonice Au; Denise Goh; Joe Poh Sheng Yeong; Hemant Mahendrakumar Kocher

doi:10.1002/cac2.12638

Cancer Communications ›› 2025, Vol. 45 ›› Issue (02) : 172 -177. DOI: 10.1002/cac2.12638

LETTER TO THE JOURNAL

The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma

Author information +

History +

PDF

Cite this article

Download citation ▾

Rachel Elizabeth Ann Fincham, Parthiban Periasamy, Craig Ryan Joseph, Jia Meng, Jeffrey Chun Tatt Lim, Felicia Wee, Konstantinos Stasinos, Michelle Rodrigues Goulart, Jiangfeng Ye, Li Yen Chong, Bijin Veonice Au, Denise Goh, Joe Poh Sheng Yeong, Hemant Mahendrakumar Kocher. The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma. Cancer Communications, 2025, 45(02): 172-177 DOI:10.1002/cac2.12638

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open. 2021; 4(4): e214708.

[2]	Froeling FE, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. Gastroenterology. 2011; 141(4): 1486-97, 97.e1-14.

[3]	Neuzillet C, Tijeras-Raballand A. Ragulan C, Cros J, Patil Y, Martinet M, et al. Inter-and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. J Pathol. 2019; 248(1): 51-65.

[4]	Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, et al. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nature Communications. 2020; 11(1): 4841.

[5]	Delvecchio FR, Fincham REA, Spear S, Clear A, Roy-Luzarraga M. Balkwill FR, et al. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Cell Mol Gastroenterol Hepatol. 2021; 12(5): 1543-65.

[6]	Aguirre GA, Goulart MR, Dalli J, Kocher HM. Arachidonate 15-lipoxygenase-mediated production of Resolvin D5(n-3 DPA) abrogates pancreatic stellate cell-induced cancer cell invasion. Front Immunol. 2023; 14: 1248547.

[7]	Goulart MR, Watt J, Siddiqui I, Lawlor RT, Imrali A, Hughes C, et al. Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. npj Precision Oncology. 2021; 5(1): 61.

[8]	Hutton C, Heider F, Blanco-Gomez A. Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021; 39(9): 1227-44.e20.

[9]	Carapuca EF, Gemenetzidis E, Feig C, Bapiro TE, Williams MD, Wilson AS, et al. Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma. J Pathol. 2016; 239(3): 286-96.

[10]	Colucci M, Zumerle S, Bressan S, Gianfanti F, Troiani M, Valdata A, et al. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell. 2024; 42(4): 646-61.e9.